Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Clear cell renal cell carcinoma (ccRCC) features metabolic dysregulation, with altered lipid metabolism and ferroptosis dysregulation driving malignancy. This review examines the interplay between lipid reprogramming and ferroptosis resistance in ccRCC pathogenesis and therapy. Tumor cells ...
This study explored medical students’ perceptions, educational needs, and cognitive biases toward Artificial Intelligence-assisted (AI-assisted) renal cell carcinoma (RCC) diagnosis, using the World Health Organization (WHO) 2022 classification. A cross-sectional survey of 249 students ...
In a groundbreaking development in oncology, researchers at the London Health Sciences Centre Research Institute (LHSCRI) have embarked on an innovative Phase II clinical trial focusing on a novel
Clear cell renal cell carcinoma (ccRCC) features metabolic dysregulation, with altered lipid metabolism and ferroptosis dysregulation driving malignancy. This review examines the interplay between lipid reprogramming and ferroptosis resistance in ccRCC pathogenesis and therapy. Tumor cells ...
Supriya Peshin: A Review of Immunotherapy in Renal Cell Carcinoma / Bicky Thapa, cancer, Nazli Dizman, OncoDaily, Oncology, Petros Grivas, Razelle Kurzrock,
Ferroptosis, a distinctive and tightly regulated form of cell death, has rapidly gained attention in the oncology community due to its potential as a therapeutic target in cancer treatment. Unlike
This clearance adds onto a previous indication for the BioTraceIO platform in liver tumor ablation.
Obesity is a well-established risk modifier for clear cell renal cell carcinoma (ccRCC), yet the molecular mechanisms underlying their ...
... clear cell renal cell carcinoma (ccRCC) remains unclear. Methods: We integrated multi-omics bioinformatics analyses from public databases (TCGA ...
The approval is supported by data from the phase 3 MK-3475A-D77 trial.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.